1. Home
  2. PODD vs AFRM Comparison

PODD vs AFRM Comparison

Compare PODD & AFRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • AFRM
  • Stock Information
  • Founded
  • PODD 2000
  • AFRM 2012
  • Country
  • PODD United States
  • AFRM United States
  • Employees
  • PODD N/A
  • AFRM N/A
  • Industry
  • PODD Medical/Dental Instruments
  • AFRM Business Services
  • Sector
  • PODD Health Care
  • AFRM Consumer Discretionary
  • Exchange
  • PODD Nasdaq
  • AFRM Nasdaq
  • Market Cap
  • PODD 23.8B
  • AFRM 21.3B
  • IPO Year
  • PODD 2007
  • AFRM 2021
  • Fundamental
  • Price
  • PODD $329.65
  • AFRM $89.85
  • Analyst Decision
  • PODD Strong Buy
  • AFRM Buy
  • Analyst Count
  • PODD 18
  • AFRM 26
  • Target Price
  • PODD $334.50
  • AFRM $80.91
  • AVG Volume (30 Days)
  • PODD 568.2K
  • AFRM 10.5M
  • Earning Date
  • PODD 11-06-2025
  • AFRM 11-06-2025
  • Dividend Yield
  • PODD N/A
  • AFRM N/A
  • EPS Growth
  • PODD N/A
  • AFRM N/A
  • EPS
  • PODD 3.32
  • AFRM 0.15
  • Revenue
  • PODD $2,359,500,000.00
  • AFRM $3,224,412,000.00
  • Revenue This Year
  • PODD $29.18
  • AFRM $22.56
  • Revenue Next Year
  • PODD $18.09
  • AFRM $22.65
  • P/E Ratio
  • PODD $96.84
  • AFRM $590.94
  • Revenue Growth
  • PODD 26.00
  • AFRM 38.80
  • 52 Week Low
  • PODD $225.37
  • AFRM $30.90
  • 52 Week High
  • PODD $353.50
  • AFRM $100.00
  • Technical
  • Relative Strength Index (RSI)
  • PODD 49.46
  • AFRM 61.39
  • Support Level
  • PODD $313.24
  • AFRM $79.40
  • Resistance Level
  • PODD $351.94
  • AFRM $90.14
  • Average True Range (ATR)
  • PODD 10.36
  • AFRM 5.10
  • MACD
  • PODD -3.44
  • AFRM 0.14
  • Stochastic Oscillator
  • PODD 40.54
  • AFRM 51.02

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About AFRM Affirm Holdings Inc.

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Share on Social Networks: